Alembic Pharma JV gets USFDA nod for antifungal topical solution

Aleor Dermaceuticals has received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Tavaborole Topical Solution, 5 per cent, Alembic Pharmaceuticals said in a BSE filing.

from Industry-Economic Times https://ift.tt/31s5pX1
via IFTTT